EP
BIIB icon

Elkfork Partners’s Biogen BIIB Stock Holding History

Elkfork Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$17.6M Sell
75,412
-12,886
-15% -$3M 0.43% 56
2019
Q2 		$20.6M Sell
88,298
-26,928
-23% -$6.22M 0.5% 48
2019
Q1 		$27.2M Buy
115,226
+25,636
+29% +$8.07M 0.68% 32
2018
Q4 		$27M Sell
89,590
-6,426
-7% -$2.05M 0.76% 29
2018
Q3 		$33.9M Sell
96,016
-6,120
-6% -$2.11M 0.81% 26
2018
Q2 		$29.6M Buy
102,136
+12,512
+14% +$3.52M 0.76% 29
2018
Q1 		$24.5M Buy
89,624
+43,248
+93% +$13.4M 0.66% 34
2017
Q4 		$14.8M Buy
46,376
+17,340
+60% +$5.56M 0.4% 57
2017
Q3 		$9.09M Buy
29,036
+5,678
+24% +$1.68M 0.26% 75
2017
Q2 		$6.34M Buy
23,358
+11,526
+97% +$3.05M 0.19% 103
2017
Q1 		$3.23M Buy
11,832
+8,024
+211% +$2.27M 0.1% 183
2016
Q4 		$1.08M Buy
+3,808
New +$1.13M 0.04% 292

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Elkfork Partners's BIIB Position: Q3 2019 in Review

Elkfork Partners reduced its Biogen (BIIB) stake by 15% in Q3 2019, selling an estimated $3M and leaving 75,412 shares worth $17.6M. The position accounts for 0.43% of the portfolio, ranked #56.

Elkfork Partners first reported a position in BIIB in Q4 2016 and has held it in 12 quarters since. The position peaked at $33.9M in Q3 2018. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

  • Elkfork Partners held 75,412 shares of Biogen worth $17.6M as of Q3 2019.
  • Elkfork Partners sold 12,886 Biogen shares in Q3 2019, an estimated $3M.
  • Biogen made up 0.43% of Elkfork Partners's portfolio in Q3 2019, its #56 holding.
  • Elkfork Partners first reported a position in Biogen in Q4 2016 and has held it in 12 quarters since.
  • Elkfork Partners's Biogen position peaked at $33.9M in Q3 2018.
  • 989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.